Pages that link to "Q74525381"
Jump to navigation
Jump to search
The following pages link to BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing (Q74525381):
Displaying 50 items.
- Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy (Q24604540) (← links)
- Mutations in BRIP1 confer high risk of ovarian cancer (Q28249514) (← links)
- Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory (Q30404123) (← links)
- Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting (Q33564013) (← links)
- The biology of ovarian cancer: new opportunities for translation (Q33622369) (← links)
- High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control (Q33759591) (← links)
- Molecular genetics complexity impeding research progress in breast and ovarian cancers (Q33858073) (← links)
- Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history (Q33869223) (← links)
- Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. (Q33918755) (← links)
- Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer (Q33918982) (← links)
- BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation (Q33930051) (← links)
- Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer (Q34113283) (← links)
- BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer (Q34145544) (← links)
- Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. (Q34159997) (← links)
- A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers. (Q34233873) (← links)
- Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer (Q34305493) (← links)
- Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells (Q34490603) (← links)
- Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome (Q34507528) (← links)
- Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1 (Q34692155) (← links)
- The inherited genetics of ovarian and endometrial cancer (Q34775177) (← links)
- Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management (Q34977063) (← links)
- Triple-negative breast cancers: an updated review on treatment options (Q35145678) (← links)
- Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer (Q35179515) (← links)
- Improved survival in BRCA2 carriers with ovarian cancer (Q35828679) (← links)
- Special Agents Hunting Down Women Silent Killer: The Emerging Role of the p38α Kinase (Q35864802) (← links)
- Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer (Q36135879) (← links)
- Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer (Q36385676) (← links)
- Adequacy of family history taking in ovarian cancer patients: a population-based study. (Q36394349) (← links)
- Patterns and functional implications of rare germline variants across 12 cancer types (Q36437964) (← links)
- Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule (Q36490048) (← links)
- Recent progress in the diagnosis and treatment of ovarian cancer (Q36622857) (← links)
- Ovarian cancer: can proteomics give new insights for therapy and diagnosis? (Q36820579) (← links)
- Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations (Q37011738) (← links)
- High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients (Q37147699) (← links)
- BRCA1 and implications for response to chemotherapy in ovarian cancer (Q37377021) (← links)
- Translational genomics in cancer research: converting profiles into personalized cancer medicine (Q37386249) (← links)
- The contribution of BRCA1 and BRCA2 to ovarian cancer (Q37453854) (← links)
- Genetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians (Q37472467) (← links)
- Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer (Q37677557) (← links)
- Moving Toward Personalized Medicine: Treatment-Focused Genetic Testing of Women Newly Diagnosed With Ovarian Cancer (Q37802823) (← links)
- Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form. (Q37967486) (← links)
- Mismatch repair deficiency in ovarian cancer -- molecular characteristics and clinical implications (Q38170877) (← links)
- Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens (Q38972979) (← links)
- Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer (Q39037299) (← links)
- Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. (Q39816174) (← links)
- Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (Q43625600) (← links)
- Hereditary ovarian cancer in Poland. (Q43683502) (← links)
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases (Q44221699) (← links)
- Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. (Q44644581) (← links)
- BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients (Q44969666) (← links)